- Home
- PMVP vs GDO Comparison
PMVP vs GDO Comparison
Compare PMVP & GDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$1.25
Company Overview
Basic Information| Metric | PMVP | GDO |
|---|---|---|
| Founded | 2013 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 68.9M | 87.6M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | PMVP | GDO |
|---|---|---|
| Price | $1.25 | $11.84 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $5.00 | N/A |
| AVG Volume (30 Days) | ★ 286.2K | 39.4K |
| Earning Date | 11-12-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.81% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.81 | $11.21 |
| 52 Week High | $1.84 | $13.04 |
Technical Indicators
Market Signals| Indicator | PMVP | GDO |
|---|---|---|
| Relative Strength Index (RSI) | 47.29 | 61.19 |
| Support Level | $1.11 | $11.63 |
| Resistance Level | $1.30 | $11.90 |
| Average True Range (ATR) | 0.07 | 0.12 |
| MACD | 0.00 | 0.02 |
| Stochastic Oscillator | 67.50 | 93.10 |
Price Performance
Historical Comparison PMVP
GDO
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.
About GDO Western Asset Global Corporate Defined Opportunity Fund Inc.
Western Asset Global Corp Defined Opp is a closed-end management investment company with a primary investment objective to provide current income. Its secondary objective is to seek capital appreciation. The Fund invests in the United States and foreign corporate fixed-income securities of varying maturities.